posted on 2021-07-30, 08:35authored byTaylor & FrancisTaylor & Francis, G.J.L.J. Snijders, Nina Notman, Amber Berdenis van Berlekom, Marjolein A. M. Sneeboer, Lotte C. Houtepen, Danny M. Nispeling, Yujie He, Stella Dracheva, Elly M. Hol, René S. Kahn Lot D. de Witte, Marco P. Boks
<div>
<table>
<tr>
<td>
<p>Supplementary table 1: <b>Extended clinocopathological information of
donors.</b></p>
<p>Supplementary table 2: <b>Primers sequences for qPCR analyses.</b></p>
<p>Supplementary table 3: <b>Geomean
of</b> <b>raw CT values of </b><b>reference genes beta-actin (<i>βactin),</i> Glyceraldehyde 3-phosphate
dehydrogenase (<i>GAPDH</i>) and Succinate Dehydrogenase Complex Flavoprotein
Subunit A (<i>SDHA) </i>for each donor and each tissue included in the gene-expression
analysis</b><b>.</b> </p>
<p>Supplementary table 4: <b>Associations between potential confounding
variables sex, age, PMD, pH, Braak-score for gene-expression data.</b></p>
<p>Supplementary figure 1: <b>QQ
plot of the p-values from discovery EWAS. </b></p>
<p>Supplementary table 5: <b>Results of the linear mixed-effects model of
DNA methylation and the interaction term.</b></p>
<p>Supplementary table
6: <b>Mean methylation
values.</b> Methylation
values per DMR of SCZ and CTR samples, separated for grey and white matter. </p><div>
<table>
<tr>
<td>
<p>Supplementary figure 2: <b>Genome information
of the four DMRs of interest.</b></p>
<p>Supplementary table 7: <b>Outcome variables for gene-expression data.</b></p>
<p>Supplementary figure 3: <b>Association </b><b>between gene expression and DMR methylation
in grey and white matter of the GFM and GTS in SCZ and CTR.</b></p>
<p>Supplementary figure 4: <b>Principal
component analysis of the DMR methylation changes</b>.</p>
</td>
</tr>
</table>
</div><p>
Supplementary table 8: <b>Overlap with CPGs or
DMRs in previous genome-wide DNA methylation studies of SCZ.</b><br></p>
</td>
</tr>
</table>
</div>
Funding
S.D. is supported by VA Merit grant I01BX002876 and by NIH/NIMH U01MH116442